Inspire Medical Systems (INSP) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

INSP Stock Forecast

Inspire Medical Systems stock forecast is as follows: an average price target of $239.55 (represents a 28.66% upside from INSP’s last price of $186.19) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.

INSP Price Target

The average price target for Inspire Medical Systems (INSP) is $239.55 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $300.00 to $170.00. This represents a potential 28.66% upside from INSP's last price of $186.19.

INSP Analyst Ratings

Buy

According to 9 Wall Street analysts, Inspire Medical Systems's rating consensus is 'Buy'. The analyst rating breakdown for INSP stock is 0 'Strong Buy' (0.00%), 5 'Buy' (55.56%), 4 'Hold' (44.44%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Inspire Medical Systems Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 05, 2024	Adam Maeder	Piper Sandler	$260.00	$199.00	30.65%	39.64%
Nov 05, 2024	David Rescott	Robert W. Baird	$252.00	$199.00	26.63%	35.35%
Oct 15, 2024	David Rescott	Robert W. Baird	$240.00	$210.46	14.04%	28.90%
Jul 29, 2024	Michael Sarcone	Jefferies	$230.00	$129.79	77.21%	23.53%
Jul 16, 2024	Richard Newitter	Truist Financial	$217.00	$138.58	56.59%	16.55%
Jul 15, 2024	Kallum Titchmarsh	Morgan Stanley	$210.00	$138.89	51.20%	12.79%
Jun 25, 2024	Adam Maeder	Piper Sandler	$255.00	$139.40	82.93%	36.96%
Jun 24, 2024	Jonathan Block	Stifel Nicolaus	$170.00	$162.46	4.64%	-8.70%
Jun 11, 2024	Paige Meyer	CFRA	$175.00	$166.31	5.22%	-6.01%
Apr 19, 2024	Shagun Singh	RBC Capital	$285.00	$241.15	18.18%	53.07%

Row per page

Go to

The latest Inspire Medical Systems stock forecast, released on Nov 05, 2024 by Adam Maeder from Piper Sandler, set a price target of $260.00, which represents a 30.65% increase from the stock price at the time of the forecast ($199.00), and a 39.64% increase from INSP last price ($186.19).

Inspire Medical Systems Price Target by Period

	1M	3M	12M
# Anlaysts	2	3	11
Avg Price Target	$256.00	$250.67	$231.27
Last Closing Price	$186.19	$186.19	$186.19
Upside/Downside	37.49%	34.63%	24.21%

In the current month, the average price target of Inspire Medical Systems stock is $256.00, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a 37.49% increase as opposed to Inspire Medical Systems's last price of $186.19. This month's average price target is up 2.13% compared to last quarter, and up 10.69% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Sep 30, 2024	Truist Financial	Market Perform	Market Perform	Hold
Sep 10, 2024	RBC Capital	Market Perform	Market Perform	Hold
Jul 29, 2024	Jefferies	Buy	Buy	Hold
Jul 15, 2024	Morgan Stanley	Overweight	Overweight	Hold
Jun 25, 2024	Piper Sandler	Overweight	Overweight	Hold
Jun 24, 2024	RBC Capital	Buy	Buy	Hold
Jun 11, 2024	CFRA	Hold	Hold	Hold
Jun 03, 2024	RBC Capital	Buy	Buy	Hold
Jun 03, 2024	Bank of America Securities	Neutral	Neutral	Hold
May 23, 2024	Oppenheimer	Perform	Perform	Hold

Row per page

Go to

Inspire Medical Systems's last stock rating was published by Truist Financial on Sep 30, 2024. The company gave INSP a "Market Perform" rating, the same as its previous rate.

Inspire Medical Systems Financial Forecast

Inspire Medical Systems Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$153.30M	$151.09M	$127.90M	$137.90M	$109.19M	$91.39M	$69.38M	$78.40M	$61.69M	$52.96M	$40.35M	$46.01M	$35.84M	$12.18M	$21.35M	$26.91M	$20.86M
Avg Forecast	$323.00M	$289.51M	$280.95M	$241.21M	$277.37M	$239.56M	$233.01M	$200.31M	$233.04M	$197.59M	$189.08M	$161.41M	$186.75M	$154.49M	$136.47M	$120.06M	$131.07M	$94.31M	$78.46M	$64.17M	$74.61M	$55.62M	$43.87M	$36.94M	$41.67M	$22.69M	$7.85M	$21.32M	$23.84M	$19.14M
High Forecast	$328.17M	$294.15M	$285.45M	$245.08M	$281.81M	$243.40M	$236.74M	$204.27M	$234.33M	$197.64M	$189.08M	$161.41M	$186.81M	$162.27M	$138.65M	$121.99M	$133.17M	$94.31M	$78.46M	$64.17M	$74.61M	$55.62M	$43.87M	$36.94M	$41.67M	$22.69M	$7.85M	$21.32M	$23.84M	$19.14M
Low Forecast	$315.78M	$283.04M	$274.67M	$235.82M	$271.17M	$234.21M	$227.80M	$194.31M	$231.51M	$197.54M	$189.08M	$161.41M	$186.74M	$148.34M	$133.42M	$117.38M	$128.14M	$94.31M	$78.46M	$64.17M	$74.61M	$55.62M	$43.87M	$36.94M	$41.67M	$22.69M	$7.85M	$21.32M	$23.84M	$19.14M
# Analysts	5	4	5	4	4	3	4	8	12	6	4	4	5	13	6	6	5	5	5	11	12	11	10	9	13	7	7	9	8	6
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.99%	1.11%	1.07%	1.05%	1.16%	1.16%	1.08%	1.05%	1.11%	1.21%	1.09%	1.10%	1.58%	1.55%	1.00%	1.13%	1.09%

Inspire Medical Systems's average Quarter revenue forecast for Dec 23 based on 5 analysts is $186.75M, with a low forecast of $186.74M, and a high forecast of $186.81M. INSP's average Quarter revenue forecast represents a 21.82% increase compared to the company's last Quarter revenue of $153.30M (Sep 23).

Inspire Medical Systems EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	5	4	5	4	4	3	4	8	12	6	4	4	5	13	6	6	5	5	5	11	12	11	10	9	13	7	7	9	8	6
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$-13.47M	$-16.60M	$-15.21M	$3.27M	$-15.43M	$-13.44M	$-15.71M	$-1.49M	$-9.47M	$-12.23M	$-15.44M	$-6.67M	$-9.55M	$-22.38M	$-15.53M	$-8.36M	$-7.58M
Avg Forecast	$-71.88M	$-64.42M	$-62.52M	$-53.68M	$-61.72M	$-53.31M	$-51.85M	$-44.58M	$-51.86M	$-43.97M	$-42.07M	$-23.52M	$-41.56M	$-34.38M	$-30.37M	$-21.38M	$-2.67M	$-22.54M	$-18.75M	$-19.44M	$-17.83M	$-13.29M	$-10.48M	$-16.84M	$-9.96M	$-5.42M	$-1.88M	$-12.81M	$-5.70M	$-4.57M
High Forecast	$-70.27M	$-62.98M	$-61.12M	$-52.48M	$-60.34M	$-52.12M	$-50.69M	$-43.24M	$-51.52M	$-43.96M	$-42.07M	$-18.82M	$-41.55M	$-33.01M	$-29.69M	$-17.11M	$-2.13M	$-22.54M	$-18.75M	$-15.55M	$-17.83M	$-13.29M	$-10.48M	$-13.47M	$-9.96M	$-5.42M	$-1.88M	$-10.25M	$-5.70M	$-4.57M
Low Forecast	$-73.03M	$-65.46M	$-63.52M	$-54.54M	$-62.71M	$-54.16M	$-52.68M	$-45.46M	$-52.14M	$-43.98M	$-42.07M	$-28.22M	$-41.57M	$-36.11M	$-30.85M	$-25.66M	$-3.20M	$-22.54M	$-18.75M	$-23.33M	$-17.83M	$-13.29M	$-10.48M	$-20.21M	$-9.96M	$-5.42M	$-1.88M	$-15.37M	$-5.70M	$-4.57M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.39%	0.55%	0.71%	-1.23%	0.68%	0.72%	0.81%	0.08%	0.71%	1.17%	0.92%	0.67%	1.76%	11.92%	1.21%	1.47%	1.66%

6 analysts predict INSP's average Quarter EBITDA for Mar 23 to be $-21.38M, with a high of $-17.11M and a low of $-25.66M. This is -752.90% lower than Inspire Medical Systems's previous annual EBITDA (Dec 22) of $3.27M.

Inspire Medical Systems Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	5	4	5	4	4	3	4	8	12	6	4	4	5	13	6	6	5	5	5	11	12	11	10	9	13	7	7	9	8	6
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$-8.54M	$-11.95M	$-15.42M	$3.15M	$-16.85M	$-14.49M	$-16.69M	$-2.39M	$-10.35M	$-13.09M	$-16.22M	$-7.48M	$-10.38M	$-23.09M	$-16.25M	$-9.08M	$-8.25M
Avg Forecast	$40.87M	$28.47M	$25.67M	$11.37M	$31.37M	$17.63M	$13.32M	$-2.80M	$21.96M	$1.88M	$-4.28M	$-25.00M	$-1.64M	$-17.77M	$-17.45M	$-22.72M	$-4.28M	$-22.98M	$-18.51M	$-20.66M	$-13.30M	$-18.69M	$-19.49M	$-17.69M	$-13.94M	$-21.94M	$-33.62M	$-13.39M	$-12.20M	$-12.55M
High Forecast	$41.72M	$29.06M	$26.20M	$11.60M	$32.03M	$18.00M	$13.60M	$3.50M	$23.48M	$1.92M	$-4.16M	$-20.00M	$7.37M	$-11.33M	$-16.94M	$-18.18M	$-3.42M	$-22.98M	$-18.51M	$-16.53M	$-13.30M	$-18.69M	$-19.49M	$-14.15M	$-13.94M	$-21.94M	$-33.62M	$-10.72M	$-12.20M	$-12.55M
Low Forecast	$39.68M	$27.64M	$24.92M	$11.04M	$30.46M	$17.12M	$12.93M	$-8.74M	$21.04M	$1.83M	$-4.37M	$-30.00M	$-14.33M	$-24.51M	$-17.81M	$-27.27M	$-5.14M	$-22.98M	$-18.51M	$-24.79M	$-13.30M	$-18.69M	$-19.49M	$-21.23M	$-13.94M	$-21.94M	$-33.62M	$-16.07M	$-12.20M	$-12.55M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.48%	0.69%	0.68%	-0.74%	0.73%	0.78%	0.81%	0.18%	0.55%	0.67%	0.92%	0.54%	0.47%	0.69%	1.21%	0.74%	0.66%

Inspire Medical Systems's average Quarter net income forecast for Mar 23 is $-22.72M, with a range of $-27.27M to $-18.18M. INSP's average Quarter net income forecast represents a -821.42% decrease compared to the company's last Quarter net income of $3.15M (Dec 22).

Inspire Medical Systems SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	5	4	5	4	4	3	4	8	12	6	4	4	5	13	6	6	5	5	5	11	12	11	10	9	13	7	7	9	8	6
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$113.25M	$112.62M	$101.99M	$94.83M	$85.60M	$76.69M	$63.56M	$58.77M	$53.24M	$48.70M	$41.91M	$38.63M	$33.22M	$26.98M	$29.05M	$28.19M	$22.43M
Avg Forecast	$296.42M	$265.69M	$257.84M	$221.37M	$254.55M	$219.85M	$213.83M	$183.83M	$213.86M	$181.33M	$173.52M	$95.18M	$171.38M	$141.78M	$125.24M	$86.53M	$105.22M	$86.55M	$72.01M	$58.89M	$68.47M	$51.04M	$40.26M	$33.90M	$38.24M	$20.82M	$7.21M	$19.57M	$21.88M	$17.56M
High Forecast	$301.17M	$269.95M	$261.96M	$224.91M	$258.62M	$223.37M	$217.26M	$187.47M	$215.05M	$181.38M	$173.52M	$114.21M	$171.44M	$148.92M	$127.24M	$103.83M	$126.27M	$86.55M	$72.01M	$58.89M	$68.47M	$51.04M	$40.26M	$33.90M	$38.24M	$20.82M	$7.21M	$19.57M	$21.88M	$17.56M
Low Forecast	$289.79M	$259.75M	$252.07M	$216.42M	$248.86M	$214.93M	$209.05M	$178.33M	$212.46M	$181.28M	$173.52M	$76.14M	$171.38M	$136.13M	$122.44M	$69.22M	$84.18M	$86.55M	$72.01M	$58.89M	$68.47M	$51.04M	$40.26M	$33.90M	$38.24M	$20.82M	$7.21M	$19.57M	$21.88M	$17.56M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.80%	0.90%	1.18%	0.90%	0.99%	1.07%	1.08%	0.86%	1.04%	1.21%	1.24%	1.01%	1.60%	3.74%	1.48%	1.29%	1.28%

Inspire Medical Systems's average Quarter SG&A projection for Dec 23 is $171.38M, based on 5 Wall Street analysts, with a range of $171.38M to $171.44M. The forecast indicates a 51.34% rise compared to INSP last annual SG&A of $113.25M (Sep 23).

Inspire Medical Systems EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	5	4	5	4	4	3	4	8	12	6	4	4	5	13	6	6	5	5	5	11	12	11	10	9	13	7	7	9	8	6
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.29	$-0.41	$-0.53	$0.11	$-0.60	$-0.53	$-0.61	$-0.09	$-0.38	$-0.48	$-0.60	$-0.28	$-0.39	$-0.88	$-0.67	$-0.38	$-0.34
Avg Forecast	$1.33	$0.93	$0.84	$0.37	$1.02	$0.58	$0.43	$-0.09	$0.72	$0.06	$-0.14	$-0.65	$-0.05	$-0.58	$-0.57	$-0.66	$-0.61	$-0.76	$-0.61	$-0.80	$-0.44	$-0.61	$-0.64	$-0.66	$-0.46	$-0.72	$-1.11	$-0.59	$-0.40	$-0.41
High Forecast	$1.36	$0.95	$0.86	$0.38	$1.05	$0.59	$0.44	$0.11	$0.77	$0.06	$-0.14	$-0.63	$0.24	$-0.37	$-0.55	$-0.64	$-0.59	$-0.76	$-0.61	$-0.80	$-0.44	$-0.61	$-0.64	$-0.66	$-0.46	$-0.72	$-1.11	$-0.59	$-0.40	$-0.41
Low Forecast	$1.30	$0.90	$0.81	$0.36	$0.99	$0.56	$0.42	$-0.29	$0.69	$0.06	$-0.14	$-0.66	$-0.47	$-0.80	$-0.58	$-0.67	$-0.62	$-0.76	$-0.61	$-0.80	$-0.44	$-0.61	$-0.64	$-0.66	$-0.46	$-0.72	$-1.11	$-0.59	$-0.40	$-0.41
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.50%	0.72%	0.80%	-0.18%	0.79%	0.87%	0.77%	0.20%	0.62%	0.75%	0.91%	0.61%	0.54%	0.80%	1.14%	0.95%	0.82%

According to 6 Wall Street analysts, Inspire Medical Systems's projected average Quarter EPS for Mar 23 is $-0.66, with a low estimate of $-0.67 and a high estimate of $-0.64. This represents a -700.26% decrease compared to INSP previous annual EPS of $0.11 (Dec 22).

Inspire Medical Systems Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
OM	Outset Medical	$0.76	$11.00	1347.37%	Buy
NVCR	NovoCure	$17.09	$68.92	303.28%	Hold
TNDM	Tandem Diabetes Care	$30.74	$79.05	157.16%	Buy
TMDX	TransMedics Group	$79.34	$126.75	59.76%	Buy
INMD	InMode	$18.49	$27.50	48.73%	Hold
NARI	Inari Medical	$49.75	$66.11	32.88%	Buy
INSP	Inspire Medical Systems	$186.19	$239.55	28.66%	Buy
DXCM	DexCom	$74.46	$81.36	9.27%	Buy
CLPT	ClearPoint Neuro	$11.09	$12.00	8.21%	Buy
PODD	Insulet	$262.00	$274.00	4.58%	Buy
GMED	Globus Medical	$84.91	$79.54	-6.32%	Buy
PEN	Penumbra	$240.49	$224.85	-6.50%	Buy
GKOS	Glaukos	$140.83	$123.44	-12.35%	Buy
SWAV	ShockWave Medical	$334.75	$258.17	-22.88%	Hold

INSP Forecast FAQ

Is Inspire Medical Systems a good buy?

Yes, according to 9 Wall Street analysts, Inspire Medical Systems (INSP) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 55.56% of INSP's total ratings.

What is INSP's price target?

Inspire Medical Systems (INSP) average price target is $239.55 with a range of $170 to $300, implying a 28.66% from its last price of $186.19. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Inspire Medical Systems stock go up soon?

According to Wall Street analysts' prediction for INSP stock, the company can go up by 28.66% (from the last price of $186.19 to the average price target of $239.55), up by 61.13% based on the highest stock price target, and down by -8.70% based on the lowest stock price target.

Can Inspire Medical Systems stock reach $300?

INSP's average twelve months analyst stock price target of $239.55 does not support the claim that Inspire Medical Systems can reach $300 in the near future.

What is Inspire Medical Systems's current price target trend?

2 Wall Street analysts forecast a $256 price target for Inspire Medical Systems (INSP) this month, up 37.49% from its last price of $186.19. Compared to the last 3 and 12 months, the average price target increased by 34.63% and increased by 24.21%, respectively.

What are Inspire Medical Systems's analysts' financial forecasts?

Inspire Medical Systems's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $950.25M (high $966.22M, low $927.48M), average EBITDA is $-211M (high $-206M, low $-215M), average net income is $59.52M (high $67.12M, low $51.77M), average SG&A $872.06M (high $886.72M, low $851.17M), and average EPS is $1.94 (high $2.19, low $1.69). INSP's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.13B (high $1.15B, low $1.11B), average EBITDA is $-252M (high $-247M, low $-257M), average net income is $106.37M (high $108.59M, low $103.28M), average SG&A $1.04B (high $1.06B, low $1.02B), and average EPS is $3.47 (high $3.54, low $3.37).

Did the INSP's actual financial results beat the analysts' financial forecasts?

Based on Inspire Medical Systems's last annual report (Dec 2023), the company's revenue was $624.8M, beating the average analysts forecast of $597.77M by 4.52%. Apple's EBITDA was $-40.271M, missing the average prediction of $-128M by -68.46%. The company's net income was $-21.153M, missing the average estimation of $-59.575M by -64.49%. Apple's SG&A was $451.96M, missing the average forecast of $524.93M by -13.90%. Lastly, the company's EPS was $-0.0007, missing the average prediction of $-1.863 by -99.96%. In terms of the last quarterly report (Sep 2023), Inspire Medical Systems's revenue was $153.3M, missing the average analysts' forecast of $154.49M by -0.77%. The company's EBITDA was $-13.471M, missing the average prediction of $-34.378M by -60.82%. Inspire Medical Systems's net income was $-8.54M, missing the average estimation of $-17.766M by -51.93%. The company's SG&A was $113.25M, missing the average forecast of $141.78M by -20.12%. Lastly, the company's EPS was $-0.29, missing the average prediction of $-0.58 by -50.00%